DiffusionGemma hits 1,000 tokens per second by ditching word-by-word generation entirely. It just doesn't run on most ...

DMEGC Solar will participate at this year’s Intersolar Europe, where it will showcase its next generation of module products, including the INFINITY RT 3.0. The evolution of the INFINITY RT series is ...

TIANJIN, China, May 25, 2026 /CNW/ -- TCL Zhonghuan ("TCL Zhonghuan Renewable Energy Technology Co., Ltd.") announced the launch of its next-generation BC (back-contact) high-efficiency module at its ...

One of the study’s most significant findings concerns solar modules mounted on tracking systems. Image: UNSW. Researchers at the University of New South Wales (UNSW) have developed the world’s first ...

The entire source code for Anthropic’s Claude Code command line interface application (not the models themselves) has been leaked and disseminated, apparently due ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

BARCELONA, Spain--(BUSINESS WIRE)--Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the launch of a new intelligent CPE reference design based on the MediaTek ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

The growing use of generative artificial intelligence (GenAI) tools for coding is transforming software engineering practices, with developers now building continuous integration and continuous ...

Within three years, no embedded software developer is going to be writing code. I know it sounds like another one of my controversial statements. But I recently used Claude Code to write the best ...

Scientists at the European Commission Joint Research Centre tested two single-junction perovskite modules outdoors for one year and reported overall stable performance, supported by a new ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...